The Effects of Polypharmacy in Older Adults

被引：228
|
作者：
Hilmer, S. N. [1 ,2 ,3 ]
Gnjidic, D. [1 ,2 ,3 ]
机构：
[1] Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia
[2] Royal N Shore Hosp, Dept Aged Care & Rehabil, St Leonards, NSW 2065, Australia
[3] Univ Sydney, Fac Med, No Clin Sch, Sydney, NSW 2006, Australia
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷 / 01期
关键词：
LOWER-EXTREMITY FUNCTION; DRUG-DRUG INTERACTIONS; PHYSICAL PERFORMANCE; FUNCTIONAL OUTCOMES; ELDERLY POPULATION; NURSING-HOME; PEOPLE; FALLS; RISK; AGE;
D O I：
10.1038/clpt.2008.224
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
An assessment of the safety and efficacy of multiple medications in older adults requires clinically relevant objective outcomes and pharmacological measures of medication exposure. Important outcomes include geriatric syndromes and objective measures of physical function. Measurements of medication exposure have evolved from merely counting the drugs to a consideration of pharmacologic principles such as drug class, dose response, and maximal effect. Emerging evidence regarding the effects of cumulative medication exposure on functions critical for independence may provide guidance for prescribers.
引用
收藏
页码：86 / 88
页数：3
相关论文
共 50 条
  • [31] Emerging approaches to polypharmacy among older adults
    Raaj S. Mehta
    Bharati D. Kochar
    Korey Kennelty
    Michael E. Ernst
    Andrew T. Chan
    Nature Aging, 2021, 1 : 347 - 356
  • [32] The association between polypharmacy and frailty in older adults
    Yang, Deng-Chi
    Su, Chien-Chou
    Yang, Yea-Huei Kao
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 289 - 290
  • [33] Polypharmacy, Older Adults, and Methacholine Challenge Testing
    Polivka, B. J.
    Ingram, I. C.
    Endicott, D.
    Beatty, B. L.
    Cavallazzi, R.
    Folz, R. J.
    Antimisiaris, D. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Polypharmacy in Older Adults with Systemic Lupus Erythematosus
    Seguin, Dale
    Peschken, Christine A.
    Grymonpre, Ruby
    St John, Phil
    Tisseverasinghe, Annaliese
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] Forms of trust and polypharmacy among older adults
    Ross, Alison
    Gillett, James
    AGEING & SOCIETY, 2021, 41 (11) : 2583 - 2598
  • [36] The Effects of Polypharmacy, Nutritional, Functional Status on the Progression of COVID-19 in Older Adults
    Kacmaz, Asiye Bahar
    Soysal, Pinar
    Tan, Semen Gokce
    Durdu, Bulent
    Akkoyunlu, Yasemin
    Ogun, Hamza
    Karakose-Okyaltirik, Fatmanur
    Bolukcu, Sibel
    Okay, Gulay
    Sumbul, Bilge
    Gulen, Bedia
    Sonmez, Ertan
    Meric-Koc, Meliha
    Kazancioglu, Rumeyza
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2021, 3 (02): : 70 - 77
  • [37] Polypharmacy in older adults with cancer undergoing radiotherapy: A review
    Novak, Jennifer
    Goldberg, Annette
    Dharmarajan, Kavita
    Amini, Arya
    Maggiore, Ronald J.
    Presley, Carolyn J.
    Nightingale, Ginah
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (06) : 778 - 783
  • [38] Polyherbacy: Herbal supplements as a form of polypharmacy in older adults
    Ness, J
    Johnson, D
    Nisly, N
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2003, 58 (05): : 478 - 478
  • [39] Polypharmacy and risk of fractures in older adults: A systematic review
    Gagnon, Marie-Eve
    Talbot, Denis
    Tremblay, Florence
    Desforges, Katherine
    Sirois, Caroline
    JOURNAL OF EVIDENCE BASED MEDICINE, 2024, 17 (01) : 145 - 171
  • [40] Research priorities to address polypharmacy in older adults with cancer
    Nightingale, Ginah
    Mohamed, Mostafa R.
    Holmes, Holly M.
    Sharma, Manvi
    Ramsdale, Erika
    Lu-Yao, Grace
    Chapman, Andrew
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (06) : 964 - 970
12345